batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Revolution spreads its PRMT5 bet 26 February 2026 Summit changes its tune again 24 February 2026 Ono moves towards new BTK inhibitor launch 19 February 2026 Novartis says no to NK cells 19 February 2026 TIGIT hangs on 18 February 2026 Astellas takes its G12D degrader pivotal 18 February 2026 Bristol’s son of Revlimid tests new FDA flexibility 17 February 2026 Lilly could broaden its Retevmo reach 16 February 2026 Load More